Stock Events

BioNexus Gene Lab 

$0.68
13
-$0.14-17.36% Friday 20:59

Statistics

Day High
-
Day Low
-
52W High
9.49
52W Low
0.31
Volume
221,520
Avg. Volume
4,252,180
Mkt Cap
12.03M
P/E Ratio
-36.22
Dividend Yield
-
Dividend
-

Earnings

30SepConfirmed
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0
0
0.01
0.01
Expected EPS
N/A
Actual EPS
0.0017

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGLC. It's not an investment recommendation.

About

Commercial Services
Miscellaneous Commercial Services
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Show more...
CEO
Employees
27
ISIN
US0906282076

Listings